Auf dieser Seite
AVTX Avalo Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$14,99
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$12,5152-Wochen-Tief
$24,2752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$793M
P/E
-3.4
EPS
$-5.84
Umsatz
$59.0K
Ihre Abzeichen
52W-Spanne
$13–$24
Analystenbewertung
STRONG BUY
Kursziel
$44
P/E
-3.4
ROE
-83.4%
Nettogewinnmarge
-132642.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
AVTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$14.99
Marktkapitalisierung (MRQ)
$793M
P/E
-3.4
EPS
$-5.84
Umsatz
$59.0K
ROE
-83.4%
52W-Spanne
$13–$24
AVTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 29. Dezember 2023 | 1-for-240 | Umgekehrt |
| 8. Juli 2022 | 1-for-12 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$59.0K2016-12-31 → 2025-12-31
EPS$-5.842016-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2022-12-31
Nettogewinnmarge-132642.4%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | AVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -3.45-Jahres-Durchschnitt ≈-1.2 | ≈-1.2 | · | · | |
| P/S | 6259.75-Jahres-Durchschnitt ≈21763.0 | ≈21763.0 | 8.0 | Überbewertet | |
| K/B (MRQ) | 1.85-Jahres-Durchschnitt ≈4577.1 | ≈4577.1 | 3.4 | Unterbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | -7.25-Jahres-Durchschnitt ≈-1644.9 | ≈-1644.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 5.15-Jahres-Durchschnitt ≈21319.7 | ≈21319.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | AVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Operating Margin (Betriebsgewinnmarge) | -123601.7%5-Jahres-Durchschnitt ≈-28457.6% | ≈-28457.6% | -1023.7% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -123018.6%5-Jahres-Durchschnitt ≈-28325.3% | ≈-28325.3% | -1023.7% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -132362.7%5-Jahres-Durchschnitt ≈-47313.8% | ≈-47313.8% | · | · | |
| Net Profit Margin (Nettogewinnmarge) | -132642.4%5-Jahres-Durchschnitt ≈-28808.3% | ≈-28808.3% | -971.4% | Schwach | |
| ROA | -58.6%5-Jahres-Durchschnitt ≈-85.0% | ≈-85.0% | -53.2% | Schwach | |
| ROE | -83.4%5-Jahres-Durchschnitt ≈-7.7% | ≈-7.7% | -53.7% | Schwach | |
| ROIC | -88.0%5-Jahres-Durchschnitt ≈-171.4% | ≈-171.4% | -61.1% | Unterdurchschnittlich |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | AVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 19.35-Jahres-Durchschnitt ≈6.8 | ≈6.8 | 5.5 | Starke Liquidität | |
| Quick Ratio | 7.65-Jahres-Durchschnitt ≈6.4 | ≈6.4 | 5.2 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | AVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -86.6%5-Jahres-Durchschnitt ≈-7.6% | ≈-7.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -85.2%5-Jahres-Durchschnitt ≈-58.6% | ≈-58.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -61.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | AVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.5 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-278.7%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.83 | $-0.59 | -39.8% |
| 31. März 2026 | Mai 11, 2026 | $-0.98 | $-1.05 | 6.3% |
| 31. Dezember 2025 | $-1.13 | $-1.49 | 24.3% | |
| 30. September 2025 | $-2.19 | $-1.69 | -29.4% | |
| 30. Juni 2025 | $-1.92 | $-1.43 | -34.0% | |
| 31. März 2025 | $-1.25 | $-1.41 | 11.6% | |
| 31. Dezember 2024 | $-7.95 | $-0.40 | -1890.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.0K | $441.0K | $2M | $18M | $5M | $7M | $7M | $7M | $28M | $1M | $0 | |
| Cost of Revenue | · | · | $1M | $3M | $1M | $300.0K | $-566.5K | $3M | $635.6K | $0 | $0 | |
| R&D Expense | · | · | · | · | · | · | · | $6M | $4M | $10M | $7M | |
| SG&A Expense | $23M | $17M | $10M | $21M | $25M | $17M | $10M | $11M | $8M | $7M | $4M | |
| Operating Expenses | $73M | $69M | $29M | $55M | $88M | $80M | $23M | $42M | $14M | $17M | $11M | |
| Operating Income | $-73M | $-69M | $-27M | $-37M | $-82M | $-73M | $-16M | $-35M | $14M | $-16M | $-11M | |
| Other Non-op | $-5M | $33M | $-42.0K | $-20.0K | $-20.0K | $409.0K | $-28.3K | $13.7K | $0 | $-391.6K | $519.8K | |
| Pretax Income | $-78M | $-35M | $-32M | $-42M | · | · | · | · | · | · | · | |
| Income Tax | $165.0K | $114.0K | $14.0K | $28.0K | $-196.0K | $-3M | $280.3K | $-49.5K | $2M | $0 | $0 | |
| Net Income | $-78M | $-35M | $-32M | $-42M | $-84M | $-64M | $-16M | $-40M | $12M | $-16M | $-10M | |
| EPS (Basic) | $-5.84 | $-7.94 | $-113.58 | $-1063.00 | · | · | · | $-1.20 | $0.42 | $-1.87 | $-4.71 | |
| EPS (Diluted) | $-5.84 | $-20.91 | $-113.58 | $-1063.00 | · | · | · | $-1.20 | $0.42 | $-1.87 | $-4.71 | |
| Shares (Basic) | 13,404,830 | 4,426,149 | 277,727 | 39,202 | · | · | · | 34,773,613 | 18,410,005 | 8,830,396 | 2,226,023 | |
| Shares (Diluted) | 13,404,830 | 7,496,389 | 277,727 | 39,202 | · | · | · | 34,773,613 | 18,754,799 | 8,830,396 | 2,226,023 | |
| EBITDA | $-73M | $-68M | $-27M | $-37M | $-80M | $-71M | $-12M | · | · | $-16M | $-11M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $135M | $7M | $13M | $55M | $19M | $4M | $11M | $2M | $5M | $21M | |
| Short-term Investments | $82M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | $0 | · | · | · | · | · | · | · | |
| Inventory | · | · | $0 | $20.0K | $38.0K | $3.0K | $21.3K | $317.9K | $382.2K | $0 | · | |
| Prepaid Expense | $7M | $4M | $843.0K | $1M | $2M | $3M | $707.0K | $732.0K | $703.2K | $391.3K | $401.6K | |
| Current Assets | $105M | $139M | $8M | $16M | $62M | $26M | $18M | $22M | $11M | $6M | $22M | |
| PP&E (Net) | · | · | · | · | · | · | $1M | $586.5K | $44.6K | $43.2K | $35.2K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $718.7K | $154.3K | $130.9K | $96.1K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $132.2K | $109.6K | $87.7K | $60.8K | |
| Goodwill | $11M | $11M | $11M | $14M | $14M | $14M | $14M | $14M | $12M | $0 | · | |
| Intangibles | · | · | · | $0 | $38.0K | $2M | $2M | $4M | $18M | $0 | · | |
| Total Assets | $116M | $151M | $21M | $33M | $80M | $44M | $36M | $70M | $43M | $6M | $22M | |
| Accounts Payable | $137.0K | $283.0K | $446.0K | $3M | $3M | $3M | $2M | $1M | $1M | $1M | $678.1K | |
| Short-term Debt | · | · | $0 | $6M | $0 | · | · | · | · | · | · | |
| Current Liabilities | $13M | $7M | $5M | $22M | $20M | $15M | $12M | $26M | $11M | $4M | $6M | |
| Capital Leases | $35.0K | $350.0K | $1M | $2M | $2M | $1M | $1M | · | · | · | · | |
| Deferred Tax | $434.0K | $270.0K | $155.0K | $141.0K | $113.0K | $90.0K | $86.0K | $69.2K | $7.1K | $0 | · | |
| Other Non-current Liabilities | $35.0K | $350.0K | $1M | $2M | $2M | $2M | $1M | $385.5K | $24.3K | $0 | $370.5K | |
| Total Liabilities | $33M | $18M | $14M | $44M | $57M | $19M | $15M | $49M | $15M | $6M | $9M | |
| Long-term Debt | · | · | · | · | · | · | · | $15M | $0 | $2M | $6M | |
| Total Debt | · | · | $0 | $6M | · | · | · | · | · | $2M | $6M | |
| Common Stock | $18.0K | $10.0K | $1.0K | $0 | $9.0K | $75.0K | $44.4K | $40.8K | $31.3K | $9.4K | $8.7K | |
| Paid-in Capital | $531M | $503M | $342M | $293M | $285M | $202M | $135M | $119M | $83M | $70M | $67M | |
| Retained Earnings | $-449M | $-370M | $-335M | $-304M | $-262M | $-178M | $-114M | $-98M | $-58M | $-70M | $-54M | |
| AOCI | $68.0K | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $83M | $133M | $7M | $-11M | $23M | $25M | $21M | $21M | $28M | $207.0K | $13M | |
| Liabilities + Equity | $116M | $151M | $21M | $33M | $80M | $44M | $36M | $70M | $43M | $6M | $22M | |
| Shares Outstanding | 18,512,757 | 10,471,934 | 801,746 | 39,294 | 39,164 | 75,004,127 | 44,384,222 | 40,804,189 | 31,266,989 | 9,434,141 | 8,650,143 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $344.0K | $169.0K | $158.0K | $166.0K | $2M | $2M | $4M | $5M | $425.5K | $26.9K | $23.5K | |
| Stock-based Comp | $14M | $6M | $3M | $8M | $8M | $7M | $3M | $2M | $1M | $2M | $394.7K | |
| Deferred Tax | $165.0K | $114.0K | $14.0K | $28.0K | $22.0K | $-196.0K | $16.7K | $-16.7K | $-832.6K | $0 | $0 | |
| Amort. of Intangibles | · | · | $0 | $38.0K | $2M | $2M | $1M | $2M | $400.0K | $0 | · | |
| Other Non-cash | $13M | $-20M | $-3M | $7M | $4M | $15M | $-9M | · | · | · | · | |
| Operating Cash Flow | $-51M | $-49M | $-31M | $-27M | $-71M | $-41M | $-19M | $-3M | $13M | $-15M | $-10M | |
| CapEx | · | · | · | $95.0K | $113.0K | $63.0K | $262.0K | $564.4K | $23.3K | $34.9K | $20.0K | |
| Investing Cash Flow | $-82M | $356.0K | $-133.0K | $-95.0K | $-113.0K | $11M | $-443.0K | $865.5K | $-19M | $-34.9K | $-20.0K | |
| Net Debt Issued | · | · | · | · | · | $0 | $-256.1K | · | · | $-3M | $-2M | |
| Stock Issued | $15M | $0 | $32M | $0 | $29M | $35M | $9M | $0 | $2M | $2M | $0 | |
| Net Stock Activity | $15M | $0 | $46M | $0 | $29M | $35M | $9M | · | · | $2M | · | |
| Financing Cash Flow | $15M | $176M | $25M | $-15M | $107M | $45M | $13M | $10M | $4M | $-1M | $20M | |
| Net Change in Cash | $-119M | $127M | $-6M | $-42M | $36M | $15M | $-7M | $8M | $-3M | $-16M | $9M | |
| Free Cash Flow | · | · | · | $-27M | $-71M | $-41M | $-19M | · | · | $-15M | $-10M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -123601.7% | -15535.6% | -1421.6% | -207.4% | -1521.6% | -1087.4% | -239.1% | · | · | · | · | |
| Net Margin | -132642.4% | -7965.8% | -1639.5% | -230.8% | -1563.1% | -947.9% | -238.5% | · | · | · | · | |
| Pretax Margin | -132362.7% | -7939.9% | -1638.8% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -123018.6% | -15497.3% | -1413.4% | -206.5% | -1490.9% | -1059.9% | -181.5% | · | · | · | · | |
| ROA | -58.6% | -40.9% | -116.1% | -73.4% | -136.1% | -159.0% | -30.3% | · | · | -120.1% | -61.8% | |
| ROE | -83.4% | -45.6% | -286.8% | 643.7% | -266.2% | -201.2% | -82.1% | · | · | -247.9% | 158.4% | |
| ROIC | -88.0% | -51.7% | -374.6% | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 20.0 | 1.8 | 0.7 | 3.1 | 1.7 | 1.5 | · | · | 1.3 | 3.7 | |
| Quick Ratio | 7.6 | 19.3 | 1.6 | 0.6 | 2.7 | 1.2 | 0.3 | · | · | 1.2 | 3.6 | |
| Debt / Equity | · | · | 0.0 | -0.5 | · | · | · | · | · | 11.4 | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | 0.2 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.3 | 0.1 | 0.2 | 0.1 | · | · | · | · | |
| Inventory Turnover | · | · | 128.4 | 118.4 | 72.7 | 24.5 | -3.3 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.49 | $12.70 | $9.11 | $-1.16 | $0.20 | $0.33 | $0.47 | · | · | $0.02 | $1.51 | |
| Revenue / Share | $0.00 | $0.06 | $6.93 | $1.92 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-3.84 | $-6.54 | $-110.47 | $-2.84 | · | · | · | · | · | · | · | |
| Cash / Share | $0.86 | $12.85 | $9.25 | $1.40 | $0.48 | $0.25 | $0.08 | · | · | $0.54 | $2.45 | |
| EPS (TTM) | $-5.84 | $-20.91 | $-113.58 | $-1063.00 | · | · | · | $-1.20 | $0.42 | $-1.87 | $-4.71 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -86.6% | -77.1% | -89.3% | 234.4% | -19.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -85.2% | -56.6% | -34.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -61.2% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $59.0K | $441.0K | $2M | $18M | $5M | $7M | $7M | $7M | $28M | $1M | $0 | |
| Net Income TTM | $-78M | $-35M | $-32M | $-42M | $-84M | $-64M | $-16M | $-40M | $12M | $-16M | $-10M | |
| Market Cap | $336M | $78M | $7M | $11.41B | $552.24B | $570.27B | $688.99B | · | · | $23.91B | $83.46B | |
| Enterprise Value | · | · | $-119.1K | $11.40B | · | · | · | · | · | $23.91B | $83.44B | |
| P/E | -3.1 | -0.4 | -0.1 | -1.1 | · | · | · | -7752.0 | 21942.9 | -1355.3 | -2048.4 | |
| P/S | 5698.2 | 176.4 | 3.8 | 631.9 | 102304.6 | 85127.8 | 102066.6 | · | · | 20737.3 | · | |
| P/B | 4.0 | 0.6 | 1.0 | -1045.1 | 23925.2 | 23218.0 | 32815.7 | · | · | 115505.6 | 6378.7 | |
| P / Tangible Book | 4.6 | 0.6 | · | · | 63953.7 | 66558.3 | · | · | · | · | · | |
| P / Cash Flow | -6.5 | -1.6 | -0.2 | -426.4 | -7789.9 | -14067.0 | -36007.8 | · | · | -1640.7 | -8211.5 | |
| P / FCF | · | · | · | -424.9 | -7777.5 | -14045.3 | -35521.4 | · | · | -1636.8 | -8195.4 | |
| EV / EBITDA | · | · | 0.0 | -305.8 | · | · | · | · | · | -1486.8 | -7578.7 | |
| EV / FCF | · | · | · | -424.6 | · | · | · | · | · | -1636.6 | -8193.9 | |
| EV / Revenue | · | · | -0.1 | 631.5 | · | · | · | · | · | 20734.9 | · | |
| Earnings Yield | -32.2% | -281.4% | -1248.1% | -87.9% | · | · | · | -0.01% | 0.00% | -0.07% | -0.05% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $59.0K | $0 | · | · | $192.0K | $249.0K | $0 | $0 | $570.0K | $236.0K | $643.0K | $475.0K | $896.0K | $15M | |
| Cost of Revenue | · | · | · | · | $0 | · | · | $-714.0K | $343.0K | $-80.0K | · | $247.0K | $708.0K | $551.0K | $619.0K | $528.0K | |
| SG&A Expense | $8M | $7M | $7M | $6M | $5M | $6M | $5M | $4M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | |
| Operating Expenses | $32M | $21M | $20M | $19M | $19M | $15M | $14M | $13M | $10M | $33M | $8M | $4M | $8M | $9M | $10M | $11M | |
| Operating Income | $-32M | $-21M | $-20M | $-19M | $-19M | $-15M | $-13M | $-13M | $-10M | $-33M | $-8M | $-4M | $-7M | $-9M | $-9M | $4M | |
| Other Non-op | $-5M | $1M | $-7M | $-3.0K | $-1M | $2M | $122M | $-5.0K | $0 | $-89M | $1.0K | $-17.0K | $0 | $-26.0K | $0 | $0 | |
| Pretax Income | $-36M | $-20M | $-14M | $-31M | $-21M | $-13M | $-35M | $23M | $98M | $-121M | $-8M | $-5M | $-8M | $-10M | $-10M | $3M | |
| Income Tax | $18.0K | $12.0K | $130.0K | $11.0K | $16.0K | $8.0K | $114.0K | $-14.0K | $7.0K | $7.0K | $-9.0K | $8.0K | $7.0K | $8.0K | $9.0K | $5.0K | |
| Net Income | $-36M | $-20M | $-14M | $-31M | $-21M | $-13M | $-35M | $23M | $98M | $-121M | $-8M | $-5M | $-8M | $-10M | $-10M | $3M | |
| EPS (Basic) | $-0.83 | $-0.98 | $-0.48 | $-2.19 | $-1.92 | $-1.25 | $128.01 | $0.98 | $4.21 | $-141.14 | $257.98 | $-26.83 | $-140.73 | $-204.00 | $-1059.61 | $0.34 | |
| EPS (Diluted) | $-0.83 | $-0.98 | $-0.48 | $-2.19 | $-1.92 | $-1.25 | $137.13 | $-2.83 | $-14.07 | $-141.14 | $257.98 | $-26.83 | $-140.73 | $-204.00 | $-1059.61 | $0.34 | |
| Shares (Basic) | 43,602,044 | 20,106,925 | · | 14,000,451 | 10,829,760 | 10,514,901 | · | 5,546,257 | 1,034,130 | 859,381 | · | 194,851 | 58,217 | 48,845 | · | 9,413,466 | |
| Shares (Diluted) | 43,602,044 | 20,106,925 | · | 14,000,451 | 10,829,760 | 10,514,901 | · | 10,784,037 | 7,653,302 | 859,381 | · | 194,851 | 58,217 | 48,845 | · | 9,413,632 | |
| EBITDA | $-32M | $-21M | · | $-19M | $-19M | $-15M | · | $-13M | $-10M | $-33M | · | $-4M | $-7M | $-9M | · | $4M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $25M | $16M | $27M | $42M | $125M | $135M | $82M | $93M | $110M | $7M | $10M | $6M | $17M | $13M | $17M | |
| Short-term Investments | $315M | $57M | $82M | $85M | $71M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | $38.0K | · | · | · | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $0 | $18.0K | $19.0K | $20.0K | $22.0K | |
| Prepaid Expense | $8M | $7M | $7M | $2M | $2M | $2M | $4M | $3M | $2M | $997.0K | $843.0K | $940.0K | $1M | $2M | $1M | $1M | |
| Current Assets | $408M | $89M | $105M | $114M | $115M | $127M | $139M | $86M | $96M | $111M | $8M | $13M | $8M | $19M | $16M | $19M | |
| Goodwill | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $14M | $14M | $14M | $14M | $14M | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Total Assets | $491M | $100M | $116M | $125M | $127M | $139M | $151M | $98M | $108M | $124M | $21M | $29M | $24M | $36M | $33M | $37M | |
| Accounts Payable | $3M | $356.0K | $137.0K | $474.0K | $2M | $681.0K | $283.0K | $2M | $654.0K | $916.0K | $446.0K | $789.0K | $751.0K | $6M | $3M | $1M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $14M | $9M | $6M | $3M | |
| Current Liabilities | $21M | $12M | $13M | $8M | $9M | $6M | $7M | $61M | $96M | $216M | $5M | $6M | $22M | $23M | $22M | $18M | |
| Capital Leases | $0 | $0 | $35.0K | $117.0K | $197.0K | $275.0K | $350.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Deferred Tax | $463.0K | $446.0K | $434.0K | $304.0K | $293.0K | $278.0K | $270.0K | $154.0K | $168.0K | $162.0K | $155.0K | $164.0K | $156.0K | $148.0K | $141.0K | $133.0K | |
| Other Non-current Liabilities | $0 | $0 | $35.0K | $117.0K | $197.0K | $275.0K | $350.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $42M | $32M | $33M | $34M | $22M | $16M | $18M | $76M | $110M | $225M | $14M | $15M | $31M | $43M | $44M | $39M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $14M | $9M | · | $3M | |
| Common Stock | $53.0K | $25.0K | $18.0K | $18.0K | $11.0K | $11.0K | $10.0K | $10.0K | $1.0K | $1.0K | $1.0K | $192.0K | $14.0K | $13.0K | $0 | $9.0K | |
| Paid-in Capital | $954M | $536M | $531M | $526M | $509M | $506M | $503M | $356M | $344M | $344M | $342M | $341M | $315M | $307M | $293M | $292M | |
| Retained Earnings | $-505M | $-468M | $-449M | $-435M | $-404M | $-383M | $-370M | $-335M | $-358M | $-456M | $-335M | $-327M | $-322M | $-314M | $-304M | $-294M | |
| AOCI | $-583.0K | $-6.0K | $68.0K | $41.0K | $-34.0K | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $449M | $68M | $83M | $92M | $105M | $123M | $133M | $21M | $-14M | $-113M | $7M | $15M | $-7M | $-6M | $-11M | $-2M | |
| Liabilities + Equity | $491M | $100M | $116M | $125M | $127M | $139M | $151M | $98M | $108M | $124M | $21M | $29M | $24M | $36M | $33M | $37M | |
| Shares Outstanding | 52,900,692 | 24,637,807 | 18,512,757 | 17,827,635 | 10,837,356 | 10,827,620 | 10,471,934 | 9,682,374 | 1,034,130 | 1,034,130 | 801,746 | 192,382,419 | 14,036,940 | 13,200,535 | 39,294 | 9,414,104 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17.0K | $17.0K | $16.0K | $59.0K | $134.0K | $135.0K | $68.0K | $34.0K | $33.0K | $34.0K | $43.0K | $41.0K | $41.0K | $33.0K | $35.0K | $34.0K | |
| Stock-based Comp | $5M | $4M | $5M | $3M | $3M | $3M | $3M | $2M | $471.0K | $629.0K | $776.0K | $953.0K | $893.0K | $855.0K | $843.0K | $731.0K | |
| Deferred Tax | $17.0K | $12.0K | $131.0K | $10.0K | $16.0K | $8.0K | $114.0K | $-14.0K | $7.0K | $7.0K | $-9.0K | $8.0K | $7.0K | $8.0K | $8.0K | $5.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | $-2M | · | · | · | $308.0K | · | · | · | $114M | · | · | · | $-993.0K | · | · | |
| Operating Cash Flow | $-20M | $-18M | $-14M | $-16M | $-11M | $-9M | $-15M | $-12M | $-16M | $-6M | $-3M | $-7M | $-11M | $-10M | $-4M | $6M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $39.0K | |
| Investing Cash Flow | $-330M | $26M | $2M | $-13M | $-71M | $0 | $0 | $0 | $0 | $356.0K | $0 | $0 | $0 | $-133.0K | $0 | $-39.0K | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $26M | · | · | · | · | |
| Financing Cash Flow | $410M | $1M | $687.0K | $14M | $-469.0K | $0 | $68M | $0 | $-472.0K | $109M | $1.0K | $11M | $598.0K | $14M | $82.0K | $0 | |
| Net Change in Cash | $60M | $9M | $-11M | $-15M | $-83M | $-9M | $53M | $-12M | $-17M | $103M | $-3M | $4M | $-10M | $4M | $-4M | $6M |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -5165.1% | · | · | · | -1589.0% | -1112.0% | -1850.9% | · | 27.4% | |
| Net Margin | · | · | · | · | · | · | · | 9251.8% | · | · | · | -2215.2% | -1274.2% | -2095.8% | · | 21.3% | |
| Pretax Margin | · | · | · | · | · | · | · | 9246.2% | · | · | · | -2211.9% | -1273.1% | -2094.1% | · | 21.4% | |
| EBITDA Margin | · | · | · | · | · | · | · | -5165.1% | · | · | · | -1589.0% | -1112.0% | -1844.0% | · | 27.4% | |
| ROA | -11.8% | -16.5% | · | -27.4% | -17.7% | -10.0% | · | 36.1% | 148.6% | -151.7% | · | -15.9% | -29.0% | -20.3% | · | 4.8% | |
| ROE | -13.1% | -20.6% | · | -54.4% | -45.6% | -261.1% | · | 128.8% | -957.0% | 204.2% | · | -82.5% | 126.8% | -26197.4% | · | 16.7% | |
| ROIC | -7.0% | -30.6% | · | -21.0% | -18.5% | -12.0% | · | -61.1% | 70.4% | 29.1% | · | -25.6% | -100.1% | -290.5% | · | 764.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.3 | 7.7 | · | 14.3 | 12.4 | 22.6 | · | 1.4 | 1.0 | 0.5 | · | 2.1 | 0.3 | 0.8 | · | 1.1 | |
| Quick Ratio | 18.9 | 7.1 | · | 14.0 | 12.2 | 22.3 | · | 1.3 | 1.0 | 0.5 | · | 1.7 | 0.3 | 0.7 | · | 0.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | -2.0 | -1.5 | · | -1.3 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.2 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | 22.5 | 34.5 | 25.0 | · | 27.8 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 33.8 | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.48 | $2.77 | · | $5.14 | $9.65 | $11.32 | · | $2.18 | $-13.16 | $-108.83 | · | $0.08 | $-0.50 | $-0.47 | · | $-0.22 | |
| Revenue / Share | · | · | · | $0.00 | · | · | · | $0.02 | $0.00 | · | · | $0.01 | $0.05 | $0.04 | · | · | |
| Cash Flow / Share | · | $-0.88 | · | · | · | $-0.90 | · | · | · | · | · | · | · | $-0.86 | · | · | |
| Cash / Share | $1.61 | $1.01 | · | $1.51 | $3.90 | $11.55 | · | $8.45 | $90.34 | $106.54 | · | $0.05 | $0.45 | $1.26 | · | $1.80 | |
| EPS (TTM) | $-4.48 | $-5.57 | · | $131.77 | $131.13 | $118.98 | · | $99.94 | $75.94 | $-50.72 | · | $-1431.17 | $-1404.00 | $-1264.65 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $441.0K | $441.0K | · | $819.0K | $806.0K | $1M | · | $2M | $17M | $17M | · | $17M | |
| Net Income TTM | $-100M | $-85M | · | $-100M | $-46M | $73M | · | $-8M | $-36M | $-143M | · | $-33M | $-25M | $-30M | · | $-51M | |
| Market Cap | $978M | $368M | · | $227M | $54M | $87M | · | $92M | $13M | $22M | · | $5.59B | $1.20B | $5.54B | · | $7.50B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.58B | $1.20B | $5.54B | · | $7.49B | |
| P/E | -4.1 | -2.7 | · | 0.1 | 0.0 | 0.1 | · | 0.1 | 0.2 | -0.4 | · | -0.0 | -0.1 | -0.3 | · | · | |
| P/S | · | · | · | · | 122.6 | 196.7 | · | 112.3 | 16.0 | 15.5 | · | 2483.0 | 70.5 | 319.5 | · | 431.7 | |
| P/B | 2.2 | 5.4 | · | 2.5 | 0.5 | 0.7 | · | 4.4 | -0.9 | -0.2 | · | 380.2 | -171.6 | -884.7 | · | -3698.8 | |
| P / Tangible Book | 2.2 | 6.4 | · | 2.8 | 0.6 | 0.8 | · | 8.7 | · | · | · | 19534.2 | · | · | · | · | |
| P / Cash Flow | · | -20.8 | · | · | · | -9.2 | · | · | · | -3.6 | · | · | · | -551.6 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 2478.5 | 71.0 | 319.1 | · | 430.9 | |
| Earnings Yield | -24.2% | -37.3% | · | 1036.7% | 2627.9% | 1485.4% | · | 1052.0% | 609.0% | -233.2% | · | -4928.3% | -1647.9% | -301.1% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $59.0K | $441.0K | $2M | $18M | $5M |
| Betriebsgewinnmarge % | -123601.7% | -15535.6% | -1421.6% | -207.4% | -1521.6% |
| Nettoergebnis | $-78M | $-35M | $-32M | $-42M | $-84M |
| Verwässerte EPS | $-5.84 | $-20.91 | $-113.58 | $-1063.00 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | -0.5 | · |
| Liquiditätsgrad | 8.1 | 20.0 | 1.8 | 0.7 | 3.1 |
| Quick Ratio | 7.6 | 19.3 | 1.6 | 0.6 | 2.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | $-27M | $-71M |
Institutionelle Eigentümer (13F) 138 Einreicher · $1.3B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
138
Gehaltener Wert
$1.3B
Neue Positionen
62
Geschlossene Positionen
27
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 62 (+23 vs. Vorquartal) | 27 (+10 vs. Vorquartal) | 47 (+12 vs. Vorquartal) | 17 (-2 vs. Vorquartal) | +38.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $94.251.992 | 5.100.216 | 7,16% | Aktien |
| BlackRock, Inc. | $80.675.418 | 4.365.553 | 6,13% | Aktien |
| Deep Track Capital, LP | $66.712.800 | 3.610.000 | 5,07% | Aktien |
| Caligan Partners LP | $58.468.244 | 3.163.866 | 4,44% | Aktien |
| TCG Crossover Management, LLC | $55.756.378 | 3.017.120 | 4,24% | Aktien |
| Affinity Asset Advisors, LLC | $53.592.000 | 2.900.000 | 4,07% | Aktien |
| STATE STREET CORP | $53.394.024 | 2.889.287 | 4,06% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $46.163.040 | 2.498.000 | 3,51% | Aktien |
| Point72 Asset Management, L.P. | $44.112.240 | 2.387.026 | 3,35% | Aktien |
| Avoro Capital Advisors LLC | $43.119.994 | 2.333.333 | 3,28% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $41.843.266 | 2.264.246 | 3,18% | Aktien |
| BVF INC/IL | $38.356.072 | 2.075.545 | 2,92% | Aktien |
| BANK OF AMERICA CORP /DE/ | $35.367.561 | 1.913.829 | 2,69% | Aktien |
| Nantahala Capital Management, LLC | $34.414.380 | 1.862.250 | 2,62% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $31.951.920 | 1.729.000 | 2,43% | Aktien |
| Soleus Capital Management, L.P. | $30.583.993 | 1.654.978 | 2,32% | Aktien |
| BRAIDWELL LP | $30.107.283 | 1.629.182 | 2,29% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $23.297.533 | 1.260.689 | 1,77% | Aktien |
| UBS Group AG | $22.343.410 | 1.209.059 | 1,70% | Aktien |
| Logos Global Management LP | $21.252.000 | 1.150.000 | 1,62% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $20.428.430 | 1.105.118 | 1,55% | Aktien |
| Commodore Capital LP | $18.818.535 | 1.018.319 | 1,43% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $18.480.000 | 1.000.000 | 1,40% | Aktien |
| GOLDMAN SACHS GROUP INC | $17.487.993 | 946.320 | 1,33% | Aktien |
| Trails Edge Capital Partners, LP | $16.481.961 | 891.881 | 1,25% | Aktien |
| AMERIPRISE FINANCIAL INC | $16.473.165 | 891.405 | 1,25% | Aktien |
| Balyasny Asset Management L.P. | $15.924.419 | 861.711 | 1,21% | Aktien |
| VANGUARD GROUP INC | $14.602.165 | 804.084 | 1,11% | Aktien |
| Vestal Point Capital, LP | $14.322.000 | 775.000 | 1,09% | Aktien |
| Seven Fleet Capital Management LP | $14.243.737 | 770.765 | 1,08% | Aktien |
| Parkman Healthcare Partners LLC | $14.161.039 | 766.290 | 1,08% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $12.973.902 | 702.051 | 0,99% | Aktien |
| Squarepoint Ops LLC | $10.889.248 | 589.245 | 0,83% | Aktien |
| BAKER BROS. ADVISORS LP | $10.164.000 | 550.000 | 0,77% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $9.247.429 | 500.402 | 0,70% | Aktien |
| Davern Capital Partners, LP | $8.660.948 | 468.666 | 0,66% | Aktien |
| Pivotal bioVenture Partners Investment Advisor LLC | $8.020.930 | 434.033 | 0,61% | Aktien |
| FRANKLIN RESOURCES INC | $7.469.450 | 404.191 | 0,57% | Aktien |
| Boxer Capital Management, LLC | $6.930.000 | 375.000 | 0,53% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $6.601.056 | 357.200 | 0,50% | Aktien |
| Caption Management, LLC | $6.371.904 | 344.800 | 0,48% | Verkaufsoption |
| NORTHERN TRUST CORP | $6.366.748 | 344.521 | 0,48% | Aktien |
| DV EQUITIES, LLC | $6.139.296 | 332.213 | 0,47% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.002.452 | 324.808 | 0,46% | Aktien |
| Velan Capital Investment Management LP | $5.995.873 | 324.452 | 0,46% | Aktien |
| CITADEL ADVISORS LLC | $5.984.434 | 323.833 | 0,45% | Aktien |
| Schonfeld Strategic Advisors LLC | $5.728.947 | 310.008 | 0,44% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5.261.293 | 284.702 | 0,40% | Aktien |
| Vivo Capital, LLC | $5.082.000 | 275.000 | 0,39% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.470.312 | 241.900 | 0,34% | Kaufoption |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Armistice Capital, LLC, Steven Boyd ×28 Einreichungen | 28. Juni 2023 | · | Erste Einreichung | Passive Anlage | SEC |
| Fremantle, LLC (fka Fremantle Corporation) 1, Randal Jones | 18. Oktober 2018 | · | Erste Einreichung | Passive Anlage | SEC |
| LRS International, LLC, Robert Moscato, Jr. ×2 Einreichungen | 18. Oktober 2018 | · | Erste Einreichung | Passive Anlage | SEC |
| Fremantle Corporation, Randal Jones | 27. November 2017 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 55 Insider · 20 Führungskräfte · 27 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Garry Arthur Neil | Chief Executive Officer | 21. Mai 2026 A | 190.314 | 0 | 0 | $0 |
| Michael F Cola | Chief Executive Officer | 1. Oktober 2021 A | 175.746 | 0 | 0 | $0 |
| Blake M Paterson | CEO and President | 20. Oktober 2015 A | · | 0 | 0 | $0 |
| Christopher Ryan Sullivan | Chief Financial Officer | 16. September 2026 M | 39.900 | 0 | 17 | $-3.722.574 |
| Schond L. Greenway | CFO | 10. Dezember 2021 P | 3.883 | 0 | 0 | $0 |
| Mariam E Morris | Chief Financial Officer | 22. Januar 2018 A | · | 0 | 0 | $0 |
| Robert Moscato Jr. | COO | 4. Dezember 2017 P | 2.592.743 | 0 | 0 | $0 |
| Mittie Doyle | Chief Medical Officer | 28. August 2026 M | 51.776 | 0 | 17 | $-2.978.234 |
| Jennifer Riley | Chief Strategy Officer | 11. August 2026 S | 37.041 | 0 | 1 | $-52.011 |
| Paul Varki | Chief Legal Officer | 10. Juni 2026 F | 32.576 | 0 | 5 | $-1.513.709 |
| Taylor Boyd | Chief Business Officer | 26. Februar 2026 A | · | 0 | 0 | $0 |
| Stephen Smolinski | Chief Commercial Officer | 4. Januar 2022 A | · | 0 | 0 | $0 |
| Jeffrey H Wilkins | Chief Medical Officer | 10. Dezember 2021 P | 33.373 | 0 | 0 | $0 |
| James Archie Harrell Jr | Chief Commercial Officer | 10. Dezember 2021 P | 36.766 | 0 | 0 | $0 |
| Simon Pedder | Executive Chairman of the Bd | 9. April 2020 F | 241.833 | 0 | 0 | $0 |
| Matthew V Phillips | Chief Commercial Officer | 23. August 2019 A | 512.500 | 0 | 0 | $0 |
| Pericles Calias | Chief Scientific Officer | 16. Juli 2019 F | 49.216 | 0 | 0 | $0 |
| Patrick J Crutcher | VP, Business Development | 1. April 2019 A | 1.634.771 | 0 | 0 | $0 |
| John Joseph Kaiser | Chief Business Officer | 18. August 2017 A | · | 0 | 0 | $0 |
| Ronald Marcus | Chief Medical Officer | 17. August 2016 A | 36.000 | 0 | 0 | $0 |
| Ron M Philip | Direktor | 30. September 2026 A | · | 0 | 0 | $0 |
| Rita Jain | Direktor | 30. September 2026 A | · | 0 | 0 | $0 |
| Kevin Robert Lind | Direktor | 30. September 2026 A | · | 0 | 0 | $0 |
| Samantha Truex | Direktor | 2. Juni 2026 A | 6.333 | 0 | 0 | $0 |
| Aaron Kantoff | Direktor | 2. Juni 2026 A | 6.333 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direktor | 2. Juni 2026 A | · | 0 | 0 | $0 |
| Gilla Kaplan | Direktor | 2. Juni 2026 A | 6.333 | 0 | 0 | $0 |
| Mitchell Chan | Direktor | 6. Mai 2026 S | 3.166 | 0 | 1 | $-72.461 |
| Jonathan Goldman | Direktor | 28. März 2026 M | 3.166 | 0 | 2 | $-162.958 |
| June Sherie Almenoff | Direktor | 17. Juni 2025 A | 3.167 | 0 | 0 | $0 |
| Magnus Persson | Direktor | 20. Dezember 2023 A | · | 0 | 0 | $0 |
| Joseph M Miller | Direktor | 31. März 2022 A | 40.582 | 0 | 0 | $0 |
| Phil Gutry | Direktor | 30. September 2021 A | · | 0 | 0 | $0 |
| Suzanne Louise Bruhn | Direktor | 30. September 2021 A | · | 0 | 0 | $0 |
| Sol J Barer | Direktor | 15. Juni 2021 A | · | 0 | 0 | $0 |
| Uli Hacksell | Direktor | 31. März 2020 A | 20.000 | 0 | 0 | $0 |
| Keith Schmidt | Direktor | 7. August 2019 A | · | 0 | 0 | $0 |
| Peter Greenleaf | Direktor | 7. August 2019 A | 112.500 | 0 | 0 | $0 |
| Isaac Blech | Direktor | 31. Dezember 2018 A | 385.452 | 0 | 0 | $0 |
| Eugene A Bauer | Direktor | 31. März 2018 A | · | 0 | 0 | $0 |
| Thomas H Aasen | Direktor | 30. Juni 2017 A | · | 0 | 0 | $0 |
| Behshad Sheldon | Direktor | 18. Mai 2016 A | · | 0 | 0 | $0 |
| Caissa Capital Management ltd. | 10%-Eigentümer | 26. Juni 2023 P | 0 | 0 | 0 | $0 |
| Randal Jones | 10%-Eigentümer | 13. August 2018 M | 0 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Peter W. Sonsini | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Ravi Viswanathan | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Harry R Weller | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Krishna Kittu Kolluri | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Scott D. Sandell | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Patrick J. Kerins | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| David M Mott | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| James M Barrett | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
| Peter J Barris | 10%-Eigentümer | 20. Oktober 2015 C | 594.245 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 18 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,83% | 21.058 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,25% | 68.958 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,17% | 142.174 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,07% | 942 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 20.003 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,02% | 198.044 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 1.073.328 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 240.501 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 17.926 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 22.825 SH | 19. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 537.095 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 3.717 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 80.300 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 11.197 SH | 10. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,00% | 140 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.675.498 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.450 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 197.384 SH | 11. September 2026 | Täglich |
AVTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 21 Analysten
KAUF
Median-Ziel
$40.50
+170,2%
10 47,6%
Starker Kauf
10 47,6%
Kauf
1 4,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
12 Analysten · 2026-10-02Mittelwert-Ziel $44.08 +194,1%
← Unter allen Zielen
Aktueller Preis $14.99
Tief$30.00
Mittelwert$44.08
Hoch$60.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | · |
| ARDX | $1.42B | -22.4 | 22.1% | -15.1% | -40.2% | · |
| OBX | · | · | · | · | · | · |
| ANNX | $750M | -3.7 | · | · | -100.7% | · |
| DSGN | $567M | -7.7 | · | · | -32.8% | · |
| GERN | $845M | -10.2 | -60.2% | · | -34.4% | · |
| ACHV | · | -4.0 | · | · | · | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| FDMT | $432M | -3.1 | 230194.6% | -164.4% | -30.2% | · |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026